Triokinase
Triokinase is an enzyme that plays a crucial role in the metabolic pathway known as glycolysis. It catalyzes the conversion of dihydroxyacetone phosphate (DHAP) into glyceraldehyde 3-phosphate (G3P), which is an essential step in the breakdown of glucose for energy production. This article will provide an overview of triokinase, its function, structure, and significance in cellular metabolism.
Function[edit]
Triokinase is an important enzyme in glycolysis, a metabolic pathway that converts glucose into pyruvate, generating ATP (adenosine triphosphate) in the process. Specifically, triokinase catalyzes the transfer of a phosphate group from ATP to DHAP, resulting in the formation of G3P. This phosphorylation reaction is crucial for the subsequent steps in glycolysis, as G3P can be further metabolized to produce ATP and other important metabolites.
Structure[edit]
Triokinase is a monomeric enzyme, meaning it consists of a single polypeptide chain. It is composed of approximately 300 amino acids and has a molecular weight of around 33 kDa. The enzyme contains a conserved ATP-binding domain, which is responsible for binding and hydrolyzing ATP during the phosphorylation reaction. Additionally, triokinase possesses a substrate-binding site that specifically recognizes DHAP, allowing for the efficient conversion of this molecule into G3P.
Significance[edit]
The activity of triokinase is essential for maintaining the proper functioning of glycolysis. By converting DHAP into G3P, triokinase ensures a continuous supply of G3P for subsequent reactions in the pathway. G3P serves as a precursor for the synthesis of ATP, a vital energy source for cellular processes. Additionally, G3P can be used for the biosynthesis of other important molecules, such as lipids and amino acids.
Clinical Relevance[edit]
Mutations in the gene encoding triokinase have been associated with a rare metabolic disorder known as triokinase deficiency. This condition is characterized by a deficiency or complete absence of triokinase activity, leading to impaired glycolysis. Individuals with triokinase deficiency may experience symptoms such as muscle weakness, exercise intolerance, and developmental delays. Diagnosis of this disorder is typically confirmed through genetic testing.
See Also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian